Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00

09 May 2026, 03:12 by Amy Steele · The Cerbat Gem

Astera Labs (NASDAQ:ALAB – Free Report) had its target price lifted by Stifel Nicolaus from $236.00 to $260.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has a buy rating on the stock.

Several other research firms also recently issued reports on ALAB. UBS Group started coverage on Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Royal Bank Of Canada restated an “outperform” rating and issued a $250.00 price objective on shares of Astera Labs in a research note on Tuesday, April 21st. Finally, Rothschild & Co Redburn assumed coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $229.65.

View Our Latest Analysis on ALAB

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $199.79 on Wednesday. The stock’s fifty day moving average price is $143.77 and its two-hundred day moving average price is $153.99. Astera Labs has a one year low of $69.26 and a one year high of $262.90. The firm has a market cap of $34.25 billion, a price-to-earnings ratio of 134.99, a P/E/G ratio of 3.23 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the company earned $0.33 EPS. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs will post 1.48 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the transaction, the general counsel owned 118,084 shares in the company, valued at $12,725,912.68. This trade represents a 7.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. This trade represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. 12.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Large investors have recently bought and sold shares of the business. PNC Financial Services Group Inc. boosted its holdings in shares of Astera Labs by 15.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 11,591 shares of the company’s stock worth $1,270,000 after purchasing an additional 1,517 shares during the period. Oslo Pensjonsforsikring AS bought a new stake in shares of Astera Labs during the 1st quarter worth approximately $75,000. Andra AP fonden grew its holdings in shares of Astera Labs by 33.8% in the first quarter. Andra AP fonden now owns 47,100 shares of the company’s stock worth $5,162,000 after purchasing an additional 11,895 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Astera Labs by 18.6% in the first quarter. Dimensional Fund Advisors LP now owns 280,637 shares of the company’s stock worth $30,691,000 after purchasing an additional 43,967 shares during the last quarter. Finally, KBC Group NV increased its stake in Astera Labs by 6.6% in the 1st quarter. KBC Group NV now owns 16,646 shares of the company’s stock worth $1,824,000 after buying an additional 1,030 shares during the period. Institutional investors own 60.47% of the company’s stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.